Application of Tendon Stem/Progenitor Cells and Platelet-Rich Plasma to Treat Tendon Injuries

Operative Techniques in Orthopaedics

Volumn 26, Issue 2, 2016, Pages 68-72

  Wang, James H C ^a   Nirmala, Xavier ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

PRP; Tendinopathy; Tendon injury; TSC

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBRIN; FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

AGE; ANALGESIA; ARTICLE; BIOLOGICAL THERAPY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELF-RENEWAL; CELL STRUCTURE; CLINICAL EFFECTIVENESS; CONNECTIVE TISSUE CELL; CYTOARCHITECTURE; DISEASE SEVERITY; HUMAN; NONHUMAN; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; TENDON INJURY; TENDON STEM CELL THERAPY; TENOCYTE; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING;

EID: 84963640804     PISSN: 10486666     EISSN: 15583848     Source Type: Journal    
DOI: 10.1053/j.oto.2015.12.008     Document Type: Article

References (61)

1. Kujala U.M., Sarna S., Kaprio J. Cumulative incidence of achilles tendon rupture and tendinopathy in male former elite athletes. Clin J Sport Med 2005, 15:133-135.
2. Scott A., Ashe M.C. Common tendinopathies in the upper and lower extremities. Curr Sports Med Rep 2006, 5:233-241.
3. Lian O.B., Engebretsen L., Bahr R. Prevalence of jumper's knee among elite athletes from different sports: A cross-sectional study. Am J Sports Med 2005, 33:561-567.
4. de Jong J.P., Nguyen J.T., Sonnema A.J.M., et al. The incidence of acute traumatic tendon injuries in the hand and wrist: A 10-year population-based study. Clin Orthop Surg 2014, 6:196-202.
5. Milgrom C., Schaffler M., Gilbert S., et al. Rotator-cuff changes in asymptomatic adults. The effect of age, hand dominance and gender. J Bone Joint Surg Br 1995, 77:296-298.
6. Zhang J., JH W. Moderate exercise mitigates the detrimental effects of aging on tendon stem cells. PLoS One 2015.
7. Morais D.S., Torres J., Guedes R.M., et al. Current approaches and future trends to promote tendon repair. Ann Biomed Eng 2015, 43:2025-2035.
8. Wang J.H. Mechanobiology of tendon. J Biomech 2006, 39:1563-1582.
9. Zhang J., Wang J.H. The effects of mechanical loading on tendons-An in vivo and in vitro model study. PLoS One 2013, 8:e71740.
10. Buchanan C.I., Marsh R.L. Effects of long-term exercise on the biomechanical properties of the Achilles tendon of guinea fowl. J Appl Physiol 2001, 90:164-171.
11. Andres B.M., Murrell G.A. Treatment of tendinopathy: What works, what does not, and what is on the horizon. Clin Orthop Relat Res 2008, 466:1539-1554.
12. Hadi M., Young J., Cooper L., et al. Surgical management of chronic ruptures of the Achilles tendon remains unclear: A systematic review of the management options. Br Med Bull 2013, 108:95-114.
13. Shelbourne K.D., Gray T., Haro M. Incidence of subsequent injury to either knee within 5 years after anterior cruciate ligament reconstruction with patellar tendon autograft. Am J Sports Med 2009, 37:246-251.
14. Ziltener J.L., Leal S., Fournier P.E. Non-steroidal anti-inflammatory drugs for athletes: An update. Ann PhysRehabil Med 2010, 53:278-288.
15. Selfe J., Alexander J., Costello J.T., et al. The effect of three different (-135 °C) whole body cryotherapy exposure durations on elite rugby league players. PLoS One 2014, 9.
16. Hausswirth C., Louis J., Bieuzen F., et al. Effects of whole-body cryotherapy vs. far-infrared vs. passive modalities on recovery from exercise-induced muscle damage in highly-trained runners. PLoS One 2011, 6:7.
17. Mayer F., Hirschmuller A., Muller S., et al. Effects of short-term treatment strategies over 4 weeks in Achilles tendinopathy. Br J Sports Med 2007, 41:29.
18. Bi Y., Ehirchiou D., Kilts T.M., et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007, 13:1219-1227.
19. Zhang J., Wang J.H. Characterization of differential properties of rabbit tendon stem cells and tenocytes. BMC Musculoskelet Disord 2010, 11:1471-2474.
20. Zhou Z., Akinbiyi T., Xu L., et al. Tendon-derived stem/progenitor cell aging: Defective self-renewal and altered fate. Aging Cell 2010, 9:911-915.
21. Rui Y.F., Lui P.P., Li G., et al. Isolation and characterization of multipotent rat tendon-derived stem cells. Tissue Eng Part A 2010, 16:1549-1558.
22. Young R.G., Butler D.L., Weber W., et al. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 1998, 16:406-413.
23. Hani A.A., David L.B., Gregory P.B., et al. Autologous mesenchymal stem cell-mediated repair of tendon. Tissue Eng 1999, 5:267-277.
24. Juncosa-Melvin N., Boivin G.P., Gooch C., et al. The effect of autologous mesenchymal stem cells on the biomechanics and histology of gel-collagen sponge constructs used for rabbit patellar tendon repair. Tissue Eng 2006, 12:369-379.
25. Marfe G., Rotta G., De Martino L., et al. A new clinical approach: Use of blood-derived stem cells (BDSCs) for superficial digital flexor tendon injuries in horses. Life Sci 2012, 90:825-830.
26. Kryger G.S., Chong A.K., Costa M., et al. A comparison of tenocytes and mesenchymal stem cells for use in flexor tendon tissue engineering. J Hand Surg Am 2007, 32:597-605.
27. Tan J., Wu W., Xu X., et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: A randomized controlled trial. J Am Med Assoc 2012, 307:1169-1177.
28. Ni M., Lui P.P.Y., Rui Y.F., et al. Tendon-derived stem cells (TDSCs) promote tendon repair in a rat patellar tendon window defect model. J Orthop Res 2012, 30:613-619.
29. Chen L., Dong S.-W., Liu J.-P., et al. Synergy of tendon stem cells and platelet-rich plasma in tendon healing. J Orthop Res 2012, 30:991-997.
30. Chen J.M., Willers C., Xu J., et al. Autologous tenocyte therapy using porcine-derived bioscaffolds for massive rotator cuff defect in rabbits. Tissue Eng 2007, 13:1479-1491.
31. Chen J., Yu Q., Wu B., et al. Autologous tenocyte therapy for experimental Achilles tendinopathy in a rabbit model. Tissue Eng Part A 2011, 17:2037-2048.
32. Holladay C, Abbah S-A, O'Dowd C, et al: Preferential tendon stem cell response to growth factor supplementation. J Tissue Eng Regen Med, 2014.
33. Zhang J., Wang J.H. Human tendon stem cells better maintain their stemness in hypoxic culture conditions. PLoS One 2013, 8.
34. Zhang J., Wang J.H. Prostaglandin E2 (PGE2) exerts biphasic effects on human tendon stem cells. PLoS One 2014, 9:e87706.
35. Wang J.H.C., Zhang J., Nirmala X. Advancements in the treatment and repair of tendon injuries. Curr Tissue Eng 2014, 3:71-81.
36. Molloy T., Wang Y., Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med 2003, 33:381-394.
37. Foster T.E., Puskas B.L., Mandelbaum B.R., et al. Platelet-rich plasma: From basic science to clinical applications. Am J Sports Med 2009, 37:2259-2272.
38. Mishra A., Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 2006, 34:1774-1778.
39. Peerbooms J.C., Sluimer J., Bruijn D.J., et al. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: Platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med 2010, 38:255-262.
40. Thanasas C., Papadimitriou G., Charalambidis C., et al. Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: A randomized controlled clinical trial. Am J Sports Med 2011, 39:2130-2134.
41. de Vos R.J., Weir A., van Schie H.T., et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial. J Am Med Assoc 2010, 303:144-149.
42. Hechtman K.S., Uribe J.W., Botto-vanDemden A., et al. Platelet-rich plasma injection reduces pain in patients with recalcitrant epicondylitis. Orthopedics 2011, 34:92.
43. Filardo G., Kon E., Di Matteo B., et al. Platelet-rich plasma injections for the treatment of refractory Achilles tendinopathy: Results at 4 years. Blood Transfus 2014, 12:533-540.
44. Filardo G., Kon E., Della Villa S., et al. Use of platelet-rich plasma for the treatment of refractory jumper's knee. Int Orthop 2010, 34:909-915.
45. Jeong D.U., Lee C.-R., Lee J.H., et al. Clinical applications of platelet-rich plasma in patellar tendinopathy. BioMed Res Int 2014, 15.
46. Sánchez M., Anitua E., Azofra J., et al. Comparison of surgically repaired achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med 2007, 35:245-251.
47. Sarrafian T.L., Wang H., Hackett E.S., et al. Comparison of Achilles tendon repair techniques in a sheep model using a cross-linked acellular porcine dermal patch and platelet-rich plasma fibrin matrix for augmentation. J Foot Ankle Surg 2010, 49:128-134.
48. de Jonge S., de Vos R.J., Weir A., et al. One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: A double-blind randomized placebo-controlled trial. Am J Sports Med 2011, 39:1623-1629.
49. Schepull T., Kvist J., Norrman H., et al. Autologous platelets have no effect on the healing of human achilles tendon ruptures: A randomized single-blind study. Am J Sports Med 2011, 39:38-47.
50. Zhang J., Middleton K.K., Fu F.H., et al. HGF mediates the anti-inflammatory effects of PRP on injured tendons. Plos One 2013, 8:e67303.
51. Zhang J., Wang J.H. PRP treatment effects on degenerative tendinopathy-An in vitro model study. Muscles Ligaments Tendons J 2014, 4:10-17. [eCollection January 2014].
52. Kannus P., Jozsa L. Histopathological changes preceding spontaneous rupture of a tendon. A controlled study of 891 patients. J Bone Joint Surg Am 1991, 73:1507-1525.
53. Zhang J., Li B., Wang J.H. The role of engineered tendon matrix in the stemness of tendon stem cells in vitro and the promotion of tendon-like tissue formation in vivo. Biomaterials 2011, 32:6972-6981.
54. Becerra J., Santos-Ruiz L., Andrades J., et al. The stem cell niche should be a key issue for cell therapy in regenerative medicine. Stem Cell Rev Rep 2011, 7:248-255.
55. Zhang J., Wang J.H. Platelet-rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes. Am J Sports Med 2010, 38:2477-2486.
56. Anitua E., Andia I., Sanchez M., et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 2005, 23:281-286.
57. Anitua E., Sanchez M., Nurden A.T., et al. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 2006, 24:227-234.
58. Chen L., Liu J.P., Tang K.L., et al. Tendon derived stem cells promote platelet-rich plasma healing in collagenase-induced rat achilles tendinopathy. Cell Physiol Biochem 2014, 34:2153-2168.
59. Hwang Y.J., Choi J.Y. Addition of mesenchymal stem cells to the scaffold of platelet-rich plasma is beneficial for the reduction of the consolidation period in mandibular distraction osteogenesis. J Oral Maxillofac Surg 2010, 68:1112-1124.
60. Murray M.M., Spindler K.P., Abreu E., et al. Collagen-platelet rich plasma hydrogel enhances primary repair of the porcine anterior cruciate ligament. J Orthop Res 2007, 25:81-91.
61. Virchenko O., Aspenberg P. How can one platelet injection after tendon injury lead to a stronger tendon after 4 weeks? Interplay between early regeneration and mechanical stimulation. Acta Orthop 2006, 77:806-812.